| Deborah Heath-barlow, | |
|
200 International Dr Ste 157, Portsmouth, NH 03801-6833 | |
| (603) 957-1877 | |
| Not Available |
| Full Name | Deborah Heath-barlow |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 200 International Dr Ste 157, Portsmouth, New Hampshire |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154093367 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Heath-barlow, 200 International Dr Ste 157, Portsmouth, NH 03801-6833 Ph: (603) 957-1877 | Deborah Heath-barlow, 200 International Dr Ste 157, Portsmouth, NH 03801-6833 Ph: (603) 957-1877 |
News Archive
IntraPace, Inc., announced today that the first commercial patients in Europe have successfully received the abiliti system as a treatment for obesity. The patients were treated at the Clinica La Luz in Madrid, Spain, and Stadtkrankenhaus Schwabach, Germany.
Eggland's Best, Inc. (EB) is proud to support Susan G. Komen for the Cure®, the world's largest breast cancer advocacy organization. For the first time in the brand's history, Eggland's Best will display the Komen for the Cure's running ribbon logo along with a pink version of their iconic "EB" stamp on their egg varieties during the autumn of 2010.
A group of researchers in Israel, the United States and other nations have made important advances in the rapidly-expanding field of "regenerative medicine," outlining for the first time connections in genetic regulation that normally prevent birth defects in heart and facial muscles.
Oxygen Biotherapeutics, Inc., a development stage biomedical company focused on developing oxygen-rich intravenous and topical products, today announced results for the fiscal year (FY) first quarter ended July 31, 2010.
Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation and disorders of the central nervous system, today announced that it has enrolled the first patient in its Phase 2b clinical trial evaluating OMS302 in patients undergoing cataract surgery.
› Verified 7 days ago
Mr. Philip Gibson, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1145 Sagamore Ave, Portsmouth, NH 03801 Phone: 603-431-6703 Fax: 603-430-3753 | |
Debra Gilligan, LCMHC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 222 Court St, Portsmouth, NH 03801 Phone: 603-487-2246 Fax: 603-964-7152 | |
Victor Stephen Piro, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 20 Ladd St Ste 404, Portsmouth, NH 03801 Phone: 603-427-1177 Fax: 603-427-6555 | |
Ms. Maria Bick, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1145 Sagamore Ave, Portsmouth, NH 03801 Phone: 603-431-6703 | |
Krista Vincent, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 8 Greenleaf Woods Dr, Portsmouth, NH 03801 Phone: 603-422-8208 Fax: 603-422-8218 | |
Marieke Charlotte Kat, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 539 Islington St, Portsmouth, NH 03801 Phone: 603-427-6565 Fax: 603-427-6555 | |
Sarah B. Titus-smith, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1145 Sagamore Ave, Portsmouth, NH 03801 Phone: 603-431-6703 Fax: 603-430-3753 |